Related Experiment Video
Updated: May 7, 2026

Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
Published on: July 18, 2019
Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis
Jiesi Xu1, Yuanyuan Li1, Wei-Dong Chen1,2
1Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.
Unlabelled:
Nonalcoholic fatty liver disease (NAFLD) is one of the major health concerns worldwide. Farnesoid X receptor (FXR) is considered a therapeutic target for treatment of NAFLD. However, the mechanism by which activation of FXR lowers hepatic triglyceride (TG) levels remains unknown. Here we investigated the role of hepatic carboxylesterase 1 (CES1) in regulating both normal and FXR-controlled lipid homeostasis. Overexpression of hepatic CES1 lowered hepatic TG and plasma glucose levels in both wild-type and diabetic mice. In contrast, knockdown of hepatic CES1 increased hepatic TG and plasma cholesterol levels. These effects likely resulted from the TG hydrolase activity of CES1, with subsequent changes in fatty acid oxidation and/or de novo lipogenesis. Activation of FXR induced hepatic CES1, and reduced the levels of hepatic and plasma TG as well as plasma cholesterol in a CES1-dependent manner.
Conclusion:
Hepatic CES1 plays a critical role in regulating both lipid and carbohydrate metabolism and FXR-controlled lipid homeostasis.
Insights
Hepatic carboxylesterase 1 (CES1) regulates lipid and glucose levels. Activating Farnesoid X receptor (FXR) lowers triglycerides by increasing CES1, offering a potential NAFLD treatment strategy.
Area of Science:
- Hepatology
- Metabolic Diseases
- Molecular Biology
Background:
- Nonalcoholic fatty liver disease (NAFLD) is a global health issue.
- Farnesoid X receptor (FXR) is a potential therapeutic target for NAFLD.
- The precise mechanism by which FXR activation reduces hepatic triglyceride (TG) levels is not fully understood.
Purpose of the Study:
- To investigate the role of hepatic carboxylesterase 1 (CES1) in lipid homeostasis.
- To elucidate the relationship between FXR activation and CES1 in regulating lipid metabolism.
Main Methods:
- Overexpression and knockdown of hepatic CES1 in wild-type and diabetic mice.
- Measurement of hepatic triglyceride, plasma glucose, and plasma cholesterol levels.
- Investigation of FXR-induced changes in CES1 expression and its downstream effects.
Main Results:
- Overexpression of hepatic CES1 reduced hepatic TG and plasma glucose.
- Knockdown of hepatic CES1 increased hepatic TG and plasma cholesterol.
- FXR activation upregulated hepatic CES1, leading to decreased hepatic and plasma TG and plasma cholesterol in a CES1-dependent manner.
Conclusions:
- Hepatic CES1 is crucial for regulating lipid and carbohydrate metabolism.
- CES1 plays a key role in FXR-mediated lipid homeostasis.
- CES1's TG hydrolase activity influences fatty acid oxidation and de novo lipogenesis.
Related Concept Videos
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
